logo
Penicillin gave D-Day landings an unlikely boost, Churchill papers show

Penicillin gave D-Day landings an unlikely boost, Churchill papers show

Independent5 days ago

Newly released documents reveal that the D-Day landings were aided by the import of penicillin from America, as Britain struggled to produce sufficient quantities of the antibiotic.
Prime Minister Winston Churchill expressed frustration in handwritten notes over Britain's inability to produce enough penicillin for the Normandy landings in 1944, leading to increased reliance on American supplies.
Preparations for D-Day included decisions on the quantities of penicillin to import, dosage for patients, and training medical staff, as most British doctors were unfamiliar with its use.
By May 24, 1944, sufficient penicillin was available for treating battle casualties in Emergency Medical Services hospitals, but not for ordinary civilian patients.
Hospitals were instructed to administer penicillin to battlefield patients en route, with injections given at intervals of no more than five hours, marking treated patients with a yellow 'PEN' label; penicillin became fully available to the general public in 1946.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Chancellor unveils £6bn NHS funding after health-centred spending review
Chancellor unveils £6bn NHS funding after health-centred spending review

The Independent

time3 hours ago

  • The Independent

Chancellor unveils £6bn NHS funding after health-centred spending review

Some £6 billion will be spent on speeding up testing and treatment in the NHS, Rachel Reeves has announced, after she placed the health service at the heart of Government spending plans. The Chancellor unveiled the investment, which includes new scanners, ambulances and urgent treatment centres aimed at providing an extra four million appointments in England over the next five years, after Wednesday's spending review. The funding is aimed at reducing waiting lists and reaching Labour's 'milestone' of ensuring the health service carries out 92% of routine operations within 18 weeks. In the review, Ms Reeves set out day-to-day spending across Government for the next three years, as well as plans for capital investment over the next four years. The NHS and defence were seen as the winners from the settlement, as both will see higher than average rises in public spending. This comes at cost of squeezing the budgets of other Whitehall departments and experts have warned tax rises may be needed later this year. The Chancellor and Sir Keir Starmer both sought to portray the review as a 'new phase' for the Government, following the criticism Labour has faced during its first year in power, including over cuts to winter fuel allowance. Ms Reeves claimed the NHS had been 'put on its knees' as a result of under-investment by the previous government, adding: 'We are investing in Britain's renewal, and we will turn that around.' The new £6 billion investment will come from the capital settlement for the NHS and will also help to speed up diagnoses with scans and treatment available in places such as shopping centres and high streets. The scale of day-to-day spending for the NHS is akin to an extra £29 billion a year. In a broadcast interview on Wednesday evening, Ms Reeves said the Government was 'confident' it could meet its pledge to reduce waiting lists after the boost to NHS spending. But while health and defence have benefited from the review, the Home Office, Ministry of Housing, Communities and Local Government, Department for Culture, Media and Sport, Department for Transport and Department for the Environment, Food and Rural Affairs are all in line for real-terms cuts in day-to-day spending. The Foreign Office is also in line for real-terms cuts, mainly as a result of a reduction in the overseas aid budget, which was slashed as part of the commitment to boost defence spending to 2.6% of gross domestic product – including the intelligence agencies – from 2027. Ms Reeves acknowledged 'not everyone has been able to get exactly what they want' following Cabinet squabbling over departmental budgets. She said 'every penny' of the spending increases had been funded through the tax and borrowing changes she had announced in her first budget. The Chancellor also insisted she would not need to mount another tax raid to pay for her plans, but experts warned the money for the NHS might still not be enough and the Government is under international pressure to boost defence funding further. Paul Johnson, of the Institute for Fiscal Studies, described the hospital waiting times target as 'enormously ambitious', adding: 'And on defence, it's entirely possible that an increase in the Nato spending target will mean that maintaining defence spending at 2.6% of GDP no longer cuts the mustard.' At a summit later this month Nato members will consider calls to increase spending to 3.5% on defence, with a future 1.5% on defence-related measures. Steven Millard, interim director of the NIESR economic research institute, said the Chancellor's non-negotiable fiscal rules, coupled with the 'small amount of headroom' in her spending plans, meant 'it is now almost inevitable that if she is to keep to her fiscal rules, she will have to raise taxes in the autumn budget'. Elsewhere, policing leaders warned forces may need to make deep cuts after their settlement was announced. The spending review provides more than £2 billion for forces, but ministers have acknowledged some of that 'spending power' will come from council tax hikes.

Addiction to ketamine rises eight-fold in a decade as powerful tranquiliser becomes popular with Gen Z
Addiction to ketamine rises eight-fold in a decade as powerful tranquiliser becomes popular with Gen Z

The Sun

time3 hours ago

  • The Sun

Addiction to ketamine rises eight-fold in a decade as powerful tranquiliser becomes popular with Gen Z

DOCTORS have sounded the alarm over an eight-fold rise in ketamine addiction in a decade. The powerful tranquilliser is popular with Generation Z because of its relatively low cost, experts say. Clinics in England treated 3,609 people of all ages for addiction last year, eight times more than 426 in 2014, figures reveal. Ketamine, also referred to as 'K' or 'Ket', numbs pain and can cause a trippy high. Dealers sell it in powder form for around £20 to £40 a gram compared with £40 to £60 a gram for low-quality cocaine. Doctors say heavy use can cause liver disease and permanently damage the bladder and kidneys. It is linked to constipation, depression and loss of mental sharpness. Many medics fail to understand how addictive it can be, an NHS report said. Led by Dr Irene Guerrini of the South London and Maudsley NHS Trust, it called the drug's prevalence 'concerning'. It said: 'As ketamine use increases, more individuals are seeking treatment for addiction. 'Long-term use can seriously harm both physical and mental health, diminishing quality of life, affecting personal relationships and impairing academic or professional performance.' Dr Guerrini called for stricter guidelines on how the NHS uses the drug and more funds for treatment and prevention. Ministers are considering uprating 34878330from a Class B to Class A drug.

Taking common contraceptive pill long-term could increase your risk of life-threatening brain tumour, scientists warn
Taking common contraceptive pill long-term could increase your risk of life-threatening brain tumour, scientists warn

The Sun

time3 hours ago

  • The Sun

Taking common contraceptive pill long-term could increase your risk of life-threatening brain tumour, scientists warn

TAKING a progesterone-only contraceptive pill for more than five years is linked to an increased risk of a life-threatening brain tumour, say scientists. Desogestrel is a synthetic progestogen hormone used in oral contraceptives, specifically the progestogen-only pill (POP) or mini-pill. 1 While it offers several benefits beyond preventing pregnancy, such as regulating the menstrual cycle, reducing heavy or painful periods, new research suggests taking it continuously for more than five years is linked to a small increased risk of developing an intracranial meningioma. An intracranial meningioma is a tumour that develops from the meninges, the layers of tissue that cover the brain and spinal cord. These tumours are typically benign (non- cancerous) and slow-growing. But they can be life-threatening depending on size, location, and growth rate. The tumours are more common in older women, but previous studies lack information on the specific type of progestogen used - and risk has not been measured for continuous, current, and long term use. In the study from France published by The BMJ, researchers set out to assess the real-life risk of the brain tumour and short-term (less than a year) and prolonged (one to seven or more years) use of oral contraceptives containing desogestrel 75µg, levonorgestrel 30µg, or levonorgestrel 50-150 µg combined with oestrogen. Their findings were based on data from the French national health data system (SNDS) for 8,391 women who had undergone surgery for intracranial meningioma in 2020-2023. Each case was matched to 10 control women without meningioma of the same age and area of residence. The results showed a small increased risk associated with use of desogestrel for more than five continuous years. An increased risk wasn't found for shorter durations or when desogestrel had been discontinued for more than one year. Women taking fat jabs need 'effective contraception' - as health chiefs warn of serious harm to unborn babies The risk was greater in women older than 45 and after prolonged use of one of the known high risk progestogens before desogestrel. Although the researchers added the risk disappeared one year after stopping taking the pill. It was estimated that 67,000 women would need to use desogestrel for one woman to need surgery for intracranial meningioma, and 17,000 women if current use was for more than five years. No increased risk was found for levonorgestrel, alone or combined with oestrogen, regardless of duration of use. The researchers suggested desogestrel be discontinued if an intracranial meningioma is identified and patients monitored rather than undergoing immediate surgery. Desogestrel safety Desogestrel, when used as a progestogen-only pill (POP), is generally considered safe and effective, but it has some potential side effects and risks. But it's important to discuss any concerns with a healthcare professional. Highly effective When taken correctly, it's more than 99 per cent effective in preventing pregnancy. No protection against STIs The POP doesn't protect against sexually transmitted infections, so it's essential to use condoms for STI protection. Important to take regularly You need to take it at or around the same time every day, without breaks between packs. Possible side effects Ovarian cysts Some users might develop small, fluid-filled cysts on their ovaries, which are generally not dangerous and often resolve on their own. When to seek medical advice

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store